Composite Lipid Emulsion for the Infant at Risk of Intestinal Failure-associated Liver Disease: The Canadian Perspective.
J Pediatr Gastroenterol Nutr
; 71(3): 283-287, 2020 09.
Article
em En
| MEDLINE
| ID: mdl-32459744
ABSTRACT
Currently, in North America we are fortunate to have a number of available options for lipid emulsions to be used in the parenteral nutrition regimens for infants and children, including for long-term parenteral nutrition given intestinal failure. Neonates and infants in particular are at risk for intestinal failure-associated liver disease (IFALD). The choice of parenteral lipid emulsion will influence the risk and severity of IFALD. The purpose of this review is to discuss the rationale for the composite lipid emulsion SMOFlipid that includes soybean, medium-chain triglycerides, olive and fish oils for IFALD, with focus on the Canadian practice and experience.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Falência Hepática
/
Enteropatias
/
Hepatopatias
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Child
/
Humans
/
Infant
/
Newborn
País como assunto:
America do norte
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article